Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

被引:469
作者
Wenning, GK [1 ]
Tison, F
Seppi, K
Sampaio, C
Diem, A
Yekhlef, F
Ghorayeb, I
Ory, F
Galitzky, M
Scaravilli, T
Bozi, M
Colosimo, C
Gilman, S
Shults, CW
Quinn, NP
Rascol, O
Poewe, W
机构
[1] Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria
[2] Hop Haut Leveque, Serv Neurol, Pessac, France
[3] Hosp Santa Maria, Ctr Neurosci, Fac Med Lisboa, Lisbon, Portugal
[4] Univ Toulouse 3, Fac Med, Pharmacol Lab, F-31062 Toulouse, France
[5] UCL, Inst Neurol, London, England
[6] Univ Roma La Sapienza, Dipartimento Sci Neurol, Rome, Italy
[7] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[8] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA
关键词
Unified Multiple System Atrophy Rating Scale; validation; internal consistency; interrater reliability;
D O I
10.1002/mds.20255
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We aimed to develop and validate a novel rating scale for multiple system atrophy (Unified Multiple System Atrophy Rating Scale - UMSARS). The scale comprises the following components: Part I, historical, 12 items; Part II, motor examination, 14 items; Part III, autonomic examination; and Part IV, global disability scale. For validation purposes, 40 MSA patients were assessed in four centers by 4 raters per center (2 senior and 2 junior raters). The raters applied the UMSARS, as well as a range of other scales, including the Unified Parkinson's Disease Rating Scale (UPDRS) and the International Cooperative Ataxia Rating Scale (ICARS). Internal consistency was high for both UMSARS-I (Crohnbach's alpha = 0.84) and UMSARS-II (Crohnbach's alpha = 0.90) sections. The interrater reliability of most of the UMSARS-I and -II items as well as of total UMSARS-I and -II subscores was substantial (k (w) = 0.6-0.8) to excellent (k (w) > 0.8). UMSARS-II correlated well with UPDRS-III and ICARS (r(s) > 0.8). Depending on the degree of the patient's disability, completion of the entire UMSARS took 30 to 45 minutes. Based on our findings, the UMSARS appears to be a multidimensional, reliable, and valid scale for semiquantitative clinical assessments of MSA patients. (C) 2004 Movement Disorder Society.
引用
收藏
页码:1391 / 1402
页数:12
相关论文
共 32 条
[1]  
AGRESTI A, 1990, KAPPA WEIGHTED CATEG
[2]  
Armitage P., 1998, Encyclopedia of Biostatistics
[3]  
BRUCKE T, 1993, ADV NEUROL, V60, P494
[4]  
Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419
[5]   A COEFFICIENT OF AGREEMENT FOR NOMINAL SCALES [J].
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1960, 20 (01) :37-46
[6]  
Cohen J., 1988, STAT POWER ANAL BEHA
[7]   Amantadine in parkinsonian patients unresponsive to levodopa: A pilot study [J].
Colosimo, C ;
Merello, M ;
Pontieri, FE .
JOURNAL OF NEUROLOGY, 1996, 243 (05) :422-425
[8]  
Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO
[9]  
2-C
[10]   INTEROBSERVER VARIATION IN HISTOPATHOLOGICAL GRADING OF CERVICAL DYSPLASIA [J].
DEVET, HCW ;
KNIPSCHILD, PG ;
SCHOUTEN, HJA ;
KOUDSTAAL, J ;
KWEE, WS ;
WILLEBRAND, D ;
STURMANS, F ;
ARENDS, JW .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (12) :1395-1398